Trademark Overview

---

On Tuesday, September 24, 2024, a trademark application was filed for HEMODETOX with the United States Patent and Trademark Office. The USPTO has given the HEMODETOX trademark a serial number of 98766820. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, September 24, 2024. This trademark is owned by Lumati Holdings LLC. The HEMODETOX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

HemoDextox is a medical treatment focus on cleaning an individuals blood from all the pathogens, bacteria, viruses and unwanted chemicals.

General Information

---

Serial Number	98766820
Word Mark	HEMODETOX
Filing Date	Tuesday, September 24, 2024
Status	630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status Date	Tuesday, September 24, 2024
Registration Number	0000000
Registration Date	NOT AVAILABLE
Mark Drawing	4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition Date	NOT AVAILABLE

Trademark Statements

---

Goods and Services

HemoDextox is a medical treatment focus on cleaning an individuals blood from all the pathogens, bacteria, viruses and unwanted chemicals.

Classification Information

---

International Class	044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes	100, 101
Class Status Code	6 - Active
Class Status Date	Tuesday, September 24, 2024
Primary Code	044
First Use Anywhere Date	Monday, July 1, 2024
First Use In Commerce Date	Monday, July 1, 2024

Trademark Owner History

---

Party Name	Lumati Holdings LLC
Party Type	10 - Original Applicant
Legal Entity Type	16 - Limited Liability Company
Address	Encinitas, CA 92024

Trademark Events

---

Event Date	Event Description
Tuesday, September 24, 2024	NEW APPLICATION ENTERED

Related Keywords

---

hemodetox bacteria pathogens viruses unwanted chemicals from blood treatment medical focus